TargetMol
Curcumenol, one of the major components of Zedoary turmeric oil, is an antibiotic drug which has anti-Y, anti-inflammation activity. Curcumenol may be safely used without inducing metabolic drug-drug interaction through P450 inhibition.
More Information
Supplier Page
TargetMol
KRIBB11
50 mg
| 98.64%
TargetMol
KRIBB11
10 mg
| 98.64%
TargetMol
TargetMol
Valrocemide, also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy.
More Information
Supplier Page
TargetMol
Valrocemide, also known as TV-1901, is an antiepileptic drug (AED). Valrocemide has a broad spectrum of anticonvulsant activity and promising potential as a new AED. Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy.
More Information
Supplier Page
IMR-1A
5 mg
| Purity Not Available
TargetMol
IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.
More Information
Supplier Page
IMR-1A
1 mg
| Purity Not Available
TargetMol
IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.
More Information
Supplier Page
IMR-1A
10 mg
| Purity Not Available
TargetMol
IMR-1A is the metabolite of IMR-1 which is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.
More Information
Supplier Page
TargetMol